HB-adMSC Allogeneic is under clinical development by Hope Biosciences and currently in Phase II for Coronavirus Disease 2019 (COVID-19).
Ken Gawrelski, an analyst from Wells Fargo, maintained the Hold rating on Bumble (BMBL – Research Report). The associated price target remains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback